Chancery Denies Alexion's Call To Revisit Fee Shift Ruling
A Delaware vice chancellor has denied a request from Alexion Pharmaceuticals Inc. to revisit a ruling that shifted fees to the company related to a discovery dispute in a breach of...To view the full article, register now.
Already a subscriber? Click here to view full article